Vibrocompression (VB)
OtherVibrocompression is a physical therapy technique, that aims to clear the airways of patients on mechanical ventilation (MV)
Other names: Techinique of physical therapy
NCT Number: NCT02604082
Randomized clinical trial, conducted in the Intensive Care Unit of the Hospital de Clinicas de Porto Alegre from october 2011 until november 2015 .
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Objective: To compare the effectiveness of techniques: vibrocompression (G1), hyperinflation with mechanical ventilation (G2) vibrocompression + hyperinflation with mechanical ventilation (G3) in the amount of aspirated secretions, mechanical ventilator time, incidence of ventilator-associated pneumonia , reintubation tracheal and mortality in mechanical ventilator. Primary outcome: weight in grams of the aspirated secretions. Secondary outcome: hemodynamic and pulmonary parameters: heart rate, respiratory rate, mean arterial pressure, peripheral arterial oxygen saturation; peak inspiratory pressure, tidal volume; dynamic compliance ; mechanical ventilator time; reintubation tracheal; Incidence of ventilator-associated pneumonia and mortality in mechanical ventilator.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vibrocompression is a physical therapy technique, that aims to clear the airways of patients on mechanical ventilation (MV)
Other names: Techinique of physical therapy
Hyperinflation technique with mechanical ventilator which aims to clear the airways of patients on mechanical ventilation
Other names: Techinique of physical therapy
Association between Vibrocompression and Hyperinflation with mechanical ventilator
Other names: Techinique of physical therapy
Time frame: up to 24 weeks.
Time frame: Through study completion, an average of 3 years.
Time frame: Through study completion, an average of 3 years.
Time frame: Through study completion, an average of 3 years.
Time frame: Through study completion, an average of 3 years.
Time frame: up to 24 weeks.
Time frame: up to 24 weeks
Time frame: up to 24 weeks
Time frame: up to 24 weeks
Time frame: up to 24 weeks
Hospital de Clinicas de Porto Alegre
Other
Acronym: ClearanceMV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03078127
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06247358
Cardiac Infarct, Cardiac Valve Disease
São Paulo, Brazil
View Trial DetailsNCT05880966
Body Weight, Mobility Limitation
Lawrence, Kansas, United States
View Trial DetailsNCT04844502
Actinomycetales Infections, Bacterial Infections
Rio de Janeiro, Brazil
View Trial Details